Oluf Dimitri Røe

Medicine and Dentistry

1. Patient 100%
2. Mesothelioma 51%
3. Pleura Mesothelioma 51%
4. Biological Marker 39%
5. Osteoclast Differentiation Factor 33%
6. Therapeutic Procedure 33%
7. Osteoprotegerin 31%
8. Inpatient 31%
9. Neoplasm 30%
10. Malignant Neoplasm 29%
11. Non Small Cell Lung Cancer 28%
12. Stomach Cancer 28%
13. Atrial Fibrillation 26%
14. Radiation Therapy 23%
15. Chemotherapy 21%
16. Serum 21%
17. Alternative Complement Pathway C3 C5 Convertase 20%
18. Nuclear Factor 20%
19. Pemetrexed 19%
20. Receptor 19%
21. Platinum 18%
22. Lung Cancer 18%
23. Asbestos 18%
24. Gene 17%
25. Cohort Analysis 17%
26. Asbestos Exposure 16%
27. Age 16%
28. Incidence 16%
29. Biopsy 15%
30. Prognostic Factor 15%
31. Diagnosis 15%
32. Immunohistochemistry 14%
33. Recurrent Disease 14%
34. Analysis 13%
35. Mitral Valve Surgery 13%
36. Oxaliplatin 12%
37. Breast Cancer 12%
38. Smoking 11%
39. Cancer Incidence 11%
40. Radiation Pneumonia 11%
41. Gastrointestinal Stromal Tumor 11%
42. Systematic Review 11%
43. Sinus Rhythm 9%
44. Persistent Atrial Fibrillation 8%
45. Female 8%
46. Carboplatin 8%
47. Childhood 8%
48. In Vitro 7%
49. Protein 7%
50. Life 7%